Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-848
Published Online: 2014-11-19
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Jian
Hu, Yi-Ming
Du, Yong-Jie
Zhu, Li-Rong
Qian, Hai
Wu, Yan
Shi, Wei-Lin
License valid from 2014-11-19